Singh RP, Agarwal R.
Prostate cancer chemoprevention by silibinin: bench to bedside.
Mol Carcinog. 2006 Jun;45(6):436-42. Review.
PMID: 16637061 [PubMed - indexed for MEDLINE]
Singh RP, Agarwal R.
Prostate cancer prevention by silibinin.
Curr Cancer Drug Targets. 2004 Feb;4(1):1-11. Review.
PMID: 14965263 [PubMed - indexed for MEDLINE]
Holick MF.
Vitamin D: its role in cancer prevention and treatment.
Prog Biophys Mol Biol. 2006 Sep;92(1):49-59. Epub 2006 Mar 10. Review.
PMID: 16566961 [PubMed - indexed for MEDLINE]
Grant WB, Garland CF, Gorham ED.
An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day.
Recent Results Cancer Res. 2007;174:225-34.
PMID: 17302200 [PubMed - in process]
Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells.
Eur J Cancer Prev. 2006 Aug;15(4):353-61.
PMID: 16835506 [PubMed - indexed fo
Laskawi R, Ellies M.
The role of botulinum toxin in the management of head and neck cancer patients.
Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):112-6.
PMID: 17413413 [PubMed - in process]
Flaig TW, Su LJ, Harrison G, Agarwal R, Glode LM.
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Int J Cancer. 2007 Jan 17; [Epub ahead of print]
PMID: 17230508 [PubMed - as supplied
Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ.
Sulindac Induces Apoptosis and Inhibits Tumor Growth in vivo in Head and Neck Squamous Cell Carcinoma.
Neoplasia. 2007 Mar;9(3):192-9.
PMID: 17401459 [PubMed - in process]
Specenier P, Vermorken JB.
The role of taxanes and targeted therapies in locally advanced head and neck cancer.
Curr Opin Oncol. 2007 May;19(3):195-201.
PMID: 17414636 [PubMed - in process]
Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P.
Does solar exposure, as indicated by the non-melanoma skin
Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.\nAjith TA, Jose N, Janardhanan KK.\nJ Exp Clin Cancer Res. 2002 Jun;21(2):213-7.\nPMID: 12148580
Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glode LM.
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Invest New Drugs. 2007 Apr;25(2):139-46. Epub 2006 Nov 1.
PMID
Yang P, Cartwright C, Chan D, Vijjeswarapu M, Ding J, Newman RA.
Zyflamend((R))-Mediated Inhibition of Human Prostate Cancer PC3 Cell Proliferation: Effects on 12-LOX and Rb Protein Phosphorylation.
Cancer Biol Ther. 2007 Feb 25;6(2) [Epub ahead of pr
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.
P R Health Sci J. 2005 Dec;24(4):269-76.
PMID: 16570523
In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice.
Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D.
J Nutr Biochem. 2005 Jun;16(6):360-7.
PMID: 15936648
Awada A, Ismael G.
The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
Curr Opin Oncol. 2007 May;19(3):177-9.
PMID: 17414633 [